Rosén, Anders http://orcid.org/0000-0001-6739-6730
Gennser, Mikael
Oscarsson, Nicklas
Kvarnström, Andreas
Sandström, Göran
Blennow, Kaj
Seeman-Lodding, Helen
Zetterberg, Henrik
Funding for this research was provided by:
Swedish society for military medical officers
Herbert and Karin Jacobsson Foundation
Swedish Research Council (2018-02532)
European Research Council (681712)
Swedish State Support for Clinical Research (ALFGBG-720931)
Alzheimer Drug Discovery Foundation (201809-2016862)
UK Dementia Research Institute at UCL
University of Gothenburg
Article History
Received: 16 March 2020
Accepted: 10 September 2020
First Online: 25 September 2020
Compliance with ethical standards
:
: HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work).
: The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.